Richard L. Lindstrom M.D., Director at HARROW HEALTH, INC. (HROW), sold 40,000 shares at $9.02 ($363K) on 2021-09-16, disclosed to the SEC on 2021-09-17.
Open-market sale of $363k HROW by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.09 | 14,160 | $129K | 35.5% |
| 2 | $9.09 | 14,160 | $129K | 35.5% |
| 3 | $9.02 | 5,840 | $53K | 14.5% |
| 4 | $9.02 | 5,840 | $53K | 14.5% |
| Total | $9.07 avg | 40,000 | $363K | 100% |
| Filing → |
| HROW | SELL | 2022-10-03 | $1.0M | — | Filing → |
| HROW | SELL | 2021-09-27 | $39K | — | Filing → |
| HROW | SELL | 2021-05-21 | $108K | — | Filing → |